A-Kinase Anchoring Protein 13 (AKAP13) Augments Progesterone Signaling in Uterine Fibroid Cells.
A Kinase Anchor Proteins
/ genetics
Adult
Animals
COS Cells
Cell Line, Tumor
Chlorocebus aethiops
Female
Gene Knockdown Techniques
Humans
Leiomyoma
/ drug therapy
MAP Kinase Signaling System
/ drug effects
Mechanotransduction, Cellular
/ drug effects
Middle Aged
Minor Histocompatibility Antigens
/ genetics
Norpregnadienes
/ pharmacology
Progesterone
/ metabolism
Proto-Oncogene Proteins
/ genetics
RNA, Small Interfering
/ metabolism
Receptors, Progesterone
/ antagonists & inhibitors
Uterine Neoplasms
/ drug therapy
Uterus
/ drug effects
Journal
The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362
Informations de publication
Date de publication:
01 03 2019
01 03 2019
Historique:
received:
01
06
2018
accepted:
10
09
2018
pubmed:
22
9
2018
medline:
18
12
2019
entrez:
22
9
2018
Statut:
ppublish
Résumé
Uterine leiomyomata (fibroids) are prevalent sex hormone‒dependent tumors with an altered response to mechanical stress. Ulipristal acetate, a selective progesterone receptor (PR) modulator, significantly reduces fibroid size in patients. However, PR signaling in fibroids and its relationship to mechanical signaling are incompletely understood. Our prior studies revealed that A-kinase anchoring protein 13 (AKAP13) was overexpressed in fibroids and contributed to altered mechanotransduction in fibroids. Because AKAP13 augmented nuclear receptor signaling in other tissues, we sought to determine whether AKAP13 might influence PR signaling in fibroids. Fibroid samples from patients treated with ulipristal acetate or placebo were examined for AKAP13 expression by using immunohistochemistry. In immortalized uterine fibroid cell lines and COS-7 cells, we observed that AKAP13 increased ligand-dependent PR activation of luciferase reporters and endogenous progesterone-responsive genes for PR-B but not PR-A. Inhibition of ERK reduced activation of PR-dependent signaling by AKAP13, but inhibition of p38 MAPK had no effect. In addition, glutathione S-transferase‒binding assays revealed that AKAP13 was bound to PR-B through its carboxyl terminus. These data suggest an intersection of mechanical signaling and PR signaling involving AKAP13 through ERK. Further elucidation of the integration of mechanical and hormonal signaling pathways in fibroids may provide insight into fibroid development and suggest new therapeutic strategies for treatment.
Identifiants
pubmed: 30239831
pii: 5096790
doi: 10.1210/jc.2018-01216
pmc: PMC6365770
doi:
Substances chimiques
A Kinase Anchor Proteins
0
AKAP13 protein, human
0
Minor Histocompatibility Antigens
0
Norpregnadienes
0
Proto-Oncogene Proteins
0
RNA, Small Interfering
0
Receptors, Progesterone
0
Progesterone
4G7DS2Q64Y
ulipristal acetate
YF7V70N02B
Banques de données
ClinicalTrials.gov
['NCT00290251']
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, N.I.H., Intramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
970-980Subventions
Organisme : NCI NIH HHS
ID : T32 CA009515
Pays : United States
Organisme : Intramural NIH HHS
ID : Z01 HD008737
Pays : United States
Références
Hum Reprod. 2017 Mar 1;32(3):531-543
pubmed: 28130434
Oncogene. 2014 Jul 31;33(31):4021-35
pubmed: 24037532
Reprod Sci. 2014 Sep;21(9):1093-107
pubmed: 25001021
Mol Interv. 2010 Apr;10(2):86-97
pubmed: 20368369
Fertil Steril. 2014 Aug;102(2):597-606
pubmed: 24934492
J Biol Chem. 2010 Apr 16;285(16):12344-54
pubmed: 20139090
Reprod Sci. 2014 Sep;21(9):1120-5
pubmed: 25001022
Nature. 1994 Dec 22-29;372(6508):739-46
pubmed: 7997261
J Clin Endocrinol Metab. 2006 Apr;91(4):1296-304
pubmed: 16464945
Obstet Gynecol Int. 2014;2014:783289
pubmed: 25110476
Diabetes. 2000 Nov;49(11):1783-93
pubmed: 11078444
J Biol Chem. 2001 Dec 14;276(50):46792-7
pubmed: 11579095
J Cell Commun Signal. 2014 Sep;8(3):179-94
pubmed: 25012731
J Biol Chem. 1995 Jun 9;270(23):13585-8
pubmed: 7775407
J Cell Physiol. 2001 Mar;186(3):414-24
pubmed: 11169981
Sci Signal. 2009 Feb 10;2(57):ra5
pubmed: 19211510
Hum Reprod. 1997 Apr;12(4):815-22
pubmed: 9159448
J Soc Gynecol Investig. 1995 May-Jun;2(3):542-51
pubmed: 9420857
Nat Rev Mol Cell Biol. 2009 Jan;10(1):63-73
pubmed: 19197333
Cell Stem Cell. 2015 Oct 1;17(4):448-61
pubmed: 26321201
Fertil Steril. 2007 Jun;87(6):1399-412
pubmed: 17307170
Fertil Steril. 2011 Feb;95(2):767-72.e1-2
pubmed: 21055739
J Lipid Res. 2008 Feb;49(2):295-307
pubmed: 18024704
Expert Rev Endocrinol Metab. 2010 Jul 1;5(4):603-614
pubmed: 21037977
J Clin Endocrinol Metab. 1998 Jun;83(6):2192-8
pubmed: 9626159
Gynecol Endocrinol. 2008 May;24(5):250-6
pubmed: 18569028
Ann N Y Acad Sci. 2004 Dec;1034:36-49
pubmed: 15731298
J Clin Endocrinol Metab. 2009 May;94(5):1768-74
pubmed: 19240153
Hum Reprod. 2009 Aug;24(8):1870-9
pubmed: 19389793
Am J Obstet Gynecol. 2000 Feb;182(2):286-95
pubmed: 10694326
Hum Reprod Update. 2018 Jan 1;24(1):59-85
pubmed: 29186429
J Biomech. 2015 Jul 16;48(10):1730-6
pubmed: 26072212
Fertil Steril. 2014 Sep;102(3):649-55
pubmed: 25106764
Semin Reprod Med. 2017 Mar;35(2):181-189
pubmed: 28278535
Endocrinology. 2000 Oct;141(10):3852-61
pubmed: 11014242
Hum Reprod. 2006 Sep;21(9):2408-16
pubmed: 16720624
Int J Gynaecol Obstet. 2010 May;109(2):121-4
pubmed: 20132932
Mol Cell Endocrinol. 2012 Jul 25;358(2):223-31
pubmed: 21672608
Oncogene. 1998 May 14;16(19):2513-26
pubmed: 9627117
N Engl J Med. 2012 Feb 2;366(5):409-20
pubmed: 22296075
J Biol Chem. 2001 Nov 23;276(47):44247-57
pubmed: 11546812
J Biol Chem. 2006 Apr 7;281(14):9118-26
pubmed: 16469733
Reprod Sci. 2014 Sep;21(9):1126-38
pubmed: 25084783
Contemp Clin Trials. 2017 Apr;55:56-62
pubmed: 28185997
J Clin Endocrinol Metab. 2014 May;99(5):E775-85
pubmed: 24606069
Am J Obstet Gynecol. 2003 Jan;188(1):100-7
pubmed: 12548202
Hum Reprod. 2008 Aug;23(8):1873-83
pubmed: 18492705
Matrix Biol. 2012 Jan;31(1):57-65
pubmed: 21983114
J Clin Endocrinol Metab. 1997 Jan;82(1):293-9
pubmed: 8989276
Am J Obstet Gynecol. 2012 Mar;206(3):211.e1-9
pubmed: 22244472
Mol Endocrinol. 1988 Feb;2(2):143-7
pubmed: 2840570
Nucl Recept Signal. 2009 Dec 31;7:e009
pubmed: 20087430
Cancer Cell. 2016 Jun 13;29(6):783-803
pubmed: 27300434
Trends Biochem Sci. 2001 Jun;26(6):384-90
pubmed: 11406412
Semin Reprod Med. 2015 Sep;33(5):357-65
pubmed: 26251118
Semin Reprod Med. 2017 Nov;35(6):487-493
pubmed: 29100236
Cancer Res. 1991 Aug 15;51(16):4470-5
pubmed: 1868468
Reproduction. 2010 Jan;139(1):247-53
pubmed: 19776098
Am J Obstet Gynecol. 2008 Apr;198(4):474.e1-11
pubmed: 18395046
Endocr Rev. 2013 Feb;34(1):130-62
pubmed: 23303565
Aust N Z J Obstet Gynaecol. 2009 Feb;49(1):77-83
pubmed: 19281585
Mol Biol Cell. 2013 May;24(9):1363-74
pubmed: 23485561
Fertil Steril. 2007 May;87(5):1166-72
pubmed: 17222838
J Clin Endocrinol Metab. 2005 Feb;90(2):953-61
pubmed: 15572421
Fertil Steril. 2014 Jul;102(1):272-281.e2
pubmed: 24825427
Clin Endocrinol (Oxf). 2008 Sep;69(3):462-70
pubmed: 18248652
Reprod Sci. 2018 Feb;25(2):198-206
pubmed: 28929861
J Cell Physiol. 2018 Sep;233(9):7143-7156
pubmed: 29574773
Biochem Biophys Res Commun. 1993 May 14;192(3):1066-72
pubmed: 8507182
Obstet Gynecol. 2008 May;111(5):1129-36
pubmed: 18448745
N Engl J Med. 2012 Feb 2;366(5):421-32
pubmed: 22296076
J Natl Cancer Inst. 2012 Dec 5;104(23):1815-24
pubmed: 23090068